THERAPY DOSSIER · th-a95b5da04791

Photobiomodulation with polychromatic light

Device

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Other
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 1

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

NCT05307445 ↗NAcompleted

Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight (polychromatic light) Therapy

Mucositis Oral · Dental Implant Failed

Enrolment: 40 · Results not recorded

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 30706950 ↗2019Reported benefit

Photobiomodulation with polychromatic light increases zone 4 survival of transverse rectus abdominis musculocutaneous flap.

RatOtherWistarMalen = 21 rats randomised into 3 groups of 7Transcutaneous light applicationApplied from a distance of 10 cm to the whole abdominal wallEither for 7 days before flap elevation as a delay procedure (group 2) or immed…

Model: Transverse rectus abdominis musculocutaneous (TRAM) flap elevation with ischaemic necrosis of the distal skin paddle, particularly zone 4

Mean skin flap necrosis was 56.17 plus or minus 23.68 per cent in controls, 30.92 plus or minus 17.46 per cent in the delay group and 22.73 plus or minus 12.98 per cent in the therapeutic photobiomodulation group, with both treated groups significantly better than control. Zone 4 vascularisation wa…

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.

Loading the evidence…